Annual Non Current Assets
$45.73 M
-$7.75 M-14.49%
December 31, 2023
Summary
- As of February 7, 2025, FHTX annual long term assets is $45.73 million, with the most recent change of -$7.75 million (-14.49%) on December 31, 2023.
- During the last 3 years, FHTX annual non current assets has fallen by -$19.17 million (-29.54%).
- FHTX annual non current assets is now -29.54% below its all-time high of $64.91 million, reached on December 31, 2020.
Performance
FHTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$37.14 M
-$1.83 M-4.69%
September 30, 2024
Summary
- As of February 7, 2025, FHTX quarterly long term assets is $37.14 million, with the most recent change of -$1.83 million (-4.69%) on September 30, 2024.
- Over the past year, FHTX quarterly non current assets has dropped by -$10.84 million (-22.60%).
- FHTX quarterly non current assets is now -42.78% below its all-time high of $64.91 million, reached on December 31, 2020.
Performance
FHTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
FHTX Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.5% | -22.6% |
3 y3 years | -29.5% | -28.8% |
5 y5 years | +1622.0% | -28.8% |
FHTX Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -24.0% | at low | -38.3% | at low |
5 y | 5-year | -29.5% | +738.1% | -42.8% | +580.6% |
alltime | all time | -29.5% | +1622.0% | -42.8% | +580.6% |
Foghorn Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $37.14 M(-4.7%) |
Jun 2024 | - | $38.96 M(-10.4%) |
Mar 2024 | - | $43.48 M(-4.9%) |
Dec 2023 | $240.18 M(-31.7%) | $45.73 M(-4.7%) |
Sep 2023 | - | $47.98 M(-2.2%) |
Jun 2023 | - | $49.08 M(-5.9%) |
Mar 2023 | - | $52.18 M(-2.4%) |
Dec 2022 | $351.40 M | $53.48 M(-4.8%) |
Sep 2022 | - | $56.17 M(-1.2%) |
Jun 2022 | - | $56.83 M(-2.8%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $58.48 M(-2.9%) |
Dec 2021 | $459.56 M(+141.0%) | $60.21 M(-3.1%) |
Sep 2021 | - | $62.12 M(-2.7%) |
Jun 2021 | - | $63.85 M(-1.1%) |
Mar 2021 | - | $64.57 M(-0.5%) |
Dec 2020 | $190.69 M(+1029.3%) | $64.91 M(+0.4%) |
Sep 2020 | - | $64.66 M(+16.8%) |
Jun 2020 | - | $55.35 M(+914.2%) |
Dec 2019 | $16.89 M(-58.2%) | $5.46 M |
Dec 2018 | $40.40 M | - |
FAQ
- What is Foghorn Therapeutics annual long term assets?
- What is the all time high annual non current assets for Foghorn Therapeutics?
- What is Foghorn Therapeutics annual non current assets year-on-year change?
- What is Foghorn Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Foghorn Therapeutics?
- What is Foghorn Therapeutics quarterly non current assets year-on-year change?
What is Foghorn Therapeutics annual long term assets?
The current annual non current assets of FHTX is $45.73 M
What is the all time high annual non current assets for Foghorn Therapeutics?
Foghorn Therapeutics all-time high annual long term assets is $64.91 M
What is Foghorn Therapeutics annual non current assets year-on-year change?
Over the past year, FHTX annual long term assets has changed by -$7.75 M (-14.49%)
What is Foghorn Therapeutics quarterly long term assets?
The current quarterly non current assets of FHTX is $37.14 M
What is the all time high quarterly non current assets for Foghorn Therapeutics?
Foghorn Therapeutics all-time high quarterly long term assets is $64.91 M
What is Foghorn Therapeutics quarterly non current assets year-on-year change?
Over the past year, FHTX quarterly long term assets has changed by -$10.84 M (-22.60%)